Comments

Belite Bio Stock Price, Quotes and Forecasts

Q: What sector and industry does Belite Bio (BLTE) operate in?

Belite Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

BLTENASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$56.60

-1.92-3.28%

At close: -

$56.60

0.000.00%

After Hours: 4:00 PM EDT

Belite Bio (BLTE) Forecast

News Earnings Belite Bio (BLTE) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Belite Bio Stock Price, Quotes and Forecasts | NASDAQ:BLTE | Benzinga

Explore Belite Bio stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BLTE.

Open	$58.22
Close	$56.60
Volume / Avg.	31.93K / 43.69K
Day Range	$56.46 - $58.22
52 Wk Range	31.01 - 86.53
Market Cap	$1.83B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	38
Short Interest	0.48%
Days to Cover	2.39

Recent News

Belite Bio Analysts See Potential For Stock Gains With Progress In Key Trials

Belite Bio Inc (NASDAQ: BLTE) stock falls after reporting Q3 net loss of $36.1M; analysts maintain Buy/Overweight rating, citing positive trial results.

Priya Nigam

Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into definitive agreement to acquire the company for total potential consideration of up to $200 million in cash.

Lisa Levin

Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular Dystrophy.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Jan

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$58.22
Close	$56.60
Volume / Avg.	31.93K / 43.69K
Day Range	$56.46 - $58.22
52 Wk Range	31.01 - 86.53
Market Cap	$1.83B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	38
Short Interest	0.48%
Days to Cover	2.39

About Belite Bio Inc

Sector

Health Care

Industry

Pharmaceuticals

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel thera...

Got Questions? Ask

How is BLTE's EV/EBITDA ratio?

What are BLTE's Bollinger Band values?

What does BLTE's DCF valuation show?

What’s driving BLTE's recent performance?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Belite Bio (BLTE) stock?

You can purchase shares of Belite Bio (NASDAQ:BLTE) through any online brokerage.

View our list of the best stock brokerages

Who are Belite Bio (BLTE) competitors?

Other companies in Belite Bio’s space includes: Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), Tarsus Pharmaceuticals (NASDAQ:TARS), ANI Pharmaceuticals (NASDAQ:ANIP) and Axsome Therapeutics (NASDAQ:AXSM).

What is the forecast, or price target, for Belite Bio (BLTE) stock?

Belite Bio has a consensus price target of $78.75.

What is the current price for Belite Bio (BLTE)?

The stock price for Belite Bio (NASDAQ: BLTE) is $56.6 last updated April 11, 2025 at 4:00 PM EDT.

Does Belite Bio (BLTE) pay a dividend?

There are no upcoming dividends for Belite Bio.

When is Belite Bio (NASDAQ:BLTE) reporting earnings?

Belite Bio’s Q1 earnings are confirmed for Monday, May 12, 2025.

Is Belite Bio (BLTE) going to split?

There is no upcoming split for Belite Bio.

What sector and industry does Belite Bio (BLTE) operate in?

Belite Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.